Resultados de la búsqueda 871-880 of 7628 for insomniaare

  1. Oncología (médica) - Ensayos clínicos

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

  2. Nefrología e hipertensión - Ensayos clínicos

    The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and ...

  3. Nefrología e hipertensión - Ensayos clínicos

    The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

  5. Fase del sueño retrasada - Médicos y departamentos - Mayo Clinic

    Obtén más información sobre este trastorno del sueño que provoca un retraso en los patrones de sueño habituales.

  6. Neurocirugía - Ensayos clínicos

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

  7. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity ...

  8. Hematología - Ensayos clínicos

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  9. Fase del sueño retrasada - Médicos y departamentos - Mayo Clinic

    A Book: Mayo Clinic Guide to Better Sleep · Boletín informativo: Mayo Clinic Health Letter — Edición digital · Mayo Clinic Family Health Book (Libro de Mayo ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...